爱思唯尔旗下期刊拒稿重投
mdpi吧
全部回复
仅看楼主
level 1
JCRQ2中科院Q4的期刊官方平均审稿52天,我的用了100多天,经历一次催稿最终拒稿重投。Thank you for submitting your manuscript to World Neurosurgery. I regret to inform you that your paper is not acceptable for publication in it's current form. We have completed the review of your manuscript and a summary of the Editor's Decision to 'Reject - Invite to Resubmit' is appended below. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers, if available, are listed at the end of this letter.We feel that the manuscript truly has merit. You have the option of resubmitting a substantially revised version of your paper, which would be considered as a new submission. If you decide to do this, you should refer to the reference number of the current paper in your cover letter and include a separate file with 'Response to Reviewer Comments' which explains in detail how the paper has been changed or not, in reply to the Editor and Reviewer comments. In addition, please select the appropriate article type that starts with the word Resubmission (i.e., Resubmission Original Article; Resubmission Literature Review; etc).Thank you for giving us the opportunity to consider your work.Kind regards这里是EIC的评论。很奇怪的是决定信里没贴全审稿人的评论,只有Reviewer2的一小部分评论,说方法学有问题,Reviewer1和3根本没有,通讯正写信argue。而且我是一作网站上是直接Rej,什么别的都没有,通讯收到的邮件是Reject - Invite to Resubmit。这是怎么回事?这篇文章还有希望吗?
2025年07月16日 16点07分 1
level 1
之前不小心漏出Manuscript id了,重发一下
2025年07月16日 16点07分 2
level 1
这不是mdpi吧吗
2025年07月16日 17点07分 3
level 1
爱思唯尔吧人太少了[泪]搜拒稿重投就到这里了。
2025年07月16日 17点07分 4
level 5
去年投了个传统的四区sci,审了半年给我找个借口拒了。转投mdpi二区,中了。中科院这个分区看看就行,不要小看了sci期刊,很多根本不接中国人稿件。
2025年07月16日 20点07分 5
level 1
吧友们我来还愿了,已重投接受!!!大三上开学第一天拿下第一篇SCI。[吐舌][吐舌][吐舌]
2025年09月02日 00点09分 6
提交了
2025年11月20日 17点11分
优秀
2025年09月03日 04点09分
请问爱斯维尔重投的时候提交修改过程的标记版本了吗?
2025年10月06日 14点10分
1